Publications
Detailed Information
HIF-1 is induced via EGFR activation and mediates resistance to anoikis-like cell death under lipid rafts/caveolae-disrupting stress
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Seong-Hee | - |
dc.contributor.author | Koo, Kyung Hee | - |
dc.contributor.author | Park, Jong-Wan | - |
dc.contributor.author | Kim, Hee-Jung | - |
dc.contributor.author | Park, Jong Bae | - |
dc.contributor.author | Kim, Yong-Nyun | - |
dc.contributor.author | Park, Byung-Kiu | - |
dc.contributor.author | Ye, Sang-Kyu | - |
dc.date.accessioned | 2012-07-02T05:54:40Z | - |
dc.date.available | 2012-07-02T05:54:40Z | - |
dc.date.issued | 2009-09 | - |
dc.identifier.citation | CARCINOGENESIS; Vol.30 12; 1997-2004 | ko_KR |
dc.identifier.issn | 0143-3334 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78090 | - |
dc.description.abstract | The plasma membrane microdomains, lipid rafts, are involved in regulation of cellular functions such as cell survival and adhesion. Cholesterol is a critical component of lipid rafts in terms of their integrity and functions and rafts disruption by cholesterol depletion can induce detachment-induced cell death. Hypoxia inducible factor-1 (HIF-1) alpha is stabilized in hypoxia and transactivates numerous genes required for cellular adaptation to hypoxia. It is also induced by non-hypoxic stimuli and contributes to cell survival. Because hypoxia inhibits cholesterol synthesis and HIF-1 alpha plays a role in this process, we here explored a possible connection between lipid rafts and HIF-1 alpha. We investigated whether HIF-1 alpha is regulated during cholesterol depletion/rafts disruption in A431 cells in normoxic conditions. Methyl-beta cyclodextrin (M beta CD), which induces cholesterol depletion, upregulated HIF-1 alpha even under normoxic conditions and this upregulation required epidermal growth factor receptor (EGFR) and extracellular signal-regulated kinase 1 and 2 activation, but not Akt activation. M beta CD treatment induced HIF-1 alpha upregulation at both the transcriptional and translational levels but not at the posttranslational levels. In addition, M beta CD robustly induced vascular endothelial growth factor production and stimulated an hypoxia response element-driven luciferase reporter activity under normoxic conditions, indicating that M beta CD-induced HIF-1 alpha is functionally activated. Both EGFR activity and HIF-1 alpha expression were higher in the attached cells than in the detached cells after M beta CD treatment. Furthermore, inhibition of HIF-1 alpha by RNA interference accelerated cell detachment, thus increasing cell death, indicating that HIF-1 alpha expression attenuates M beta CD-induced anoikis-like cell death. These data suggest that, depending on cholesterol levels, lipid rafts or membrane fluidity are probably to regulate HIF-1 alpha expression in normoxia by modulating rafts protein activities such as EGFR, and this connection between lipid rafts and HIF-1 alpha regulation may provide cell survival under membrane-disturbing stress. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | OXFORD UNIV PRESS | ko_KR |
dc.title | HIF-1 is induced via EGFR activation and mediates resistance to anoikis-like cell death under lipid rafts/caveolae-disrupting stress | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이성희 | - |
dc.contributor.AlternativeAuthor | 구경희 | - |
dc.contributor.AlternativeAuthor | 박종완 | - |
dc.contributor.AlternativeAuthor | 김희중 | - |
dc.contributor.AlternativeAuthor | 예상규 | - |
dc.contributor.AlternativeAuthor | 박종배 | - |
dc.contributor.AlternativeAuthor | 박병규 | - |
dc.contributor.AlternativeAuthor | 김용년 | - |
dc.identifier.doi | 10.1093/carcin/bgp233 | - |
dc.citation.journaltitle | CARCINOGENESIS | - |
dc.description.citedreference | Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531 | - |
dc.description.citedreference | Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09 | - |
dc.description.citedreference | Gauthaman K, 2009, J CELL BIOCHEM, V106, P975, DOI 10.1002/jcb.22092 | - |
dc.description.citedreference | Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470 | - |
dc.description.citedreference | Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839 | - |
dc.description.citedreference | Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102 | - |
dc.description.citedreference | Magura L, 2008, CANCER CAUSE CONTROL, V19, P1259, DOI 10.1007/s10552-008-9197-7 | - |
dc.description.citedreference | Diebold I, 2008, THROMB HAEMOSTASIS, V100, P1021, DOI 10.1160/TH08-07-0473 | - |
dc.description.citedreference | Song G, 2008, CANCER SCI, V99, P1901, DOI 10.1111/j.1349-7006.2008.00911.x | - |
dc.description.citedreference | Laura B, 2008, J CELL BIOCHEM, V105, P503, DOI 10.1002/jcb.21850 | - |
dc.description.citedreference | Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93 | - |
dc.description.citedreference | Fedida-Metula S, 2008, CARCINOGENESIS, V29, P1546, DOI 10.1093/carcin/bgn146 | - |
dc.description.citedreference | Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177 | - |
dc.description.citedreference | Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002 | - |
dc.description.citedreference | Nishimoto-Hazuku A, 2008, J CARDIOVASC PHARM, V51, P267 | - |
dc.description.citedreference | Shin DH, 2008, ONCOGENE, V27, P1939, DOI 10.1038/sj.onc.1210826 | - |
dc.description.citedreference | Indovina P, 2008, ANTICANCER RES, V28, P1013 | - |
dc.description.citedreference | Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200 | - |
dc.description.citedreference | Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2 | - |
dc.description.citedreference | Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008 | - |
dc.description.citedreference | Freeman MR, 2007, STEROIDS, V72, P210, DOI 10.1016/j.steroids.2006.11.012 | - |
dc.description.citedreference | Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7 | - |
dc.description.citedreference | Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011 | - |
dc.description.citedreference | Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200 | - |
dc.description.citedreference | Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837 | - |
dc.description.citedreference | Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925 | - |
dc.description.citedreference | Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959 | - |
dc.description.citedreference | Hwang JI, 2005, P NATL ACAD SCI USA, V102, P9493, DOI 10.1073/pnas.0503503102 | - |
dc.description.citedreference | Zhuang LY, 2005, J CLIN INVEST, V115, P959 | - |
dc.description.citedreference | Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012 | - |
dc.description.citedreference | Chen SD, 2005, ANN NY ACAD SCI, V1042, P357, DOI 10.1196/annals.1338.033 | - |
dc.description.citedreference | Koike T, 2004, P NATL ACAD SCI USA, V101, P8132 | - |
dc.description.citedreference | Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200 | - |
dc.description.citedreference | Kim YN, 2000, J BIOL CHEM, V275, P7481 | - |
dc.description.citedreference | Zhong H, 2000, CANCER RES, V60, P1541 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.